Voyager Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Participate in Upcoming Investor Conference

Rhea-AI Summary

Voyager Therapeutics (NASDAQ: VYGR) will announce its fourth quarter and full year 2020 financial results on February 25, 2021, after market close. A conference call is scheduled for 4:30 p.m. EST to discuss the results and provide a corporate update. Participants can access the call via a designated phone number or through a live webcast on the company's website. Additionally, Voyager will take part in the Cowen 41st Annual Health Care Conference on March 1, 2021 at 11:40 a.m. EST.

Positive

• Scheduled conference call to discuss financial results indicating transparency.
• Participation in Cowen 41st Annual Health Care Conference highlights company engagement with investors.

Negative

• None.

CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, will report fourth quarter and full year 2020 financial results after market close on Thursday, February 25, 2021. Subsequently, at 4:30 p.m. EST, the Company will host a live conference call and webcast to discuss its financial results and provide a corporate update.

The conference call may be accessed by dialing (877) 851-3834 for domestic callers, or +1 (631) 291-4595 for international callers. Please reference conference ID number 3688928 to join the call. The conference call will be webcast live from the Investors & Media section of Voyager’s website at www.voyagertherapeutics.com and will be archived there following the call for 90 days.

Additionally, the company will participate in a panel discussion at the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021 at 11:40 a.m. EST.

The webcast session may be accessed from the Investors & Media section of Voyager’s website at www.voyagertherapeutics.com. Replays of the webcast will be archived on the Company's website for at least 30 days.

About Voyager Therapeutics

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager’s wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, and other severe neurological diseases. For more information on Voyager Therapeutics, please visit the company’s website at www.voyagertherapeutics.com or follow @VoyagerTx on Twitter and LinkedIn.

Investors:

Investors@voyagertherapeutics.com

Media:

Sheryl Seapy
W2Opure
949-903-4750
sseapy@purecommunications.com

FAQ

When will Voyager Therapeutics report its financial results for Q4 and full year 2020?

Voyager Therapeutics will report its financial results on February 25, 2021.

What time is the Voyager Therapeutics conference call?

The conference call is scheduled for 4:30 p.m. EST on February 25, 2021.

How can I access the Voyager Therapeutics conference call?

The conference call can be accessed by calling (877) 851-3834 for domestic callers or +1 (631) 291-4595 for international callers.

What is the date of the Cowen 41st Annual Health Care Conference?

The Cowen 41st Annual Health Care Conference is on March 1, 2021.